National Institute of Allergy and Infectious Diseases
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

Preclinical Development of Therapeutic Agents
 Eligibility Criteria
 Assurances to Users
 Application Process
 Approval Process
 User Requirements
 Examples of Services by Category


Services for Researchers

Services for the Preclinical Development of Therapeutic Agents

About

What services does this resource provide?

The Services for the Preclinical Development of Therapeutic Agents program offers a collection of preclinical services to support the development of promising therapeutic candidates, including those for lead identification and development, chemistry and manufacturing, in vitro microbiological services; in vitro and in vivo preclinical safety, toxicology and biokinetics; and preclinical development planning and evaluation. These services shall be directed at diseases caused by category A, B, and C priority pathogens and toxins, emerging and re-emerging infectious diseases, antimicrobial resistant and multi-drug resistant infections, other bacterial infections, fungal infections, viral infections, and parasitic diseases. Examples of services within each of these categories are listed here.

Who provides the services?

SRI International is the prime contractor.

Access


Contact Info

Program Officers, their areas of responsibility, and contact information may be found at the DMID Staff Lists.

Overall coordination of the program is managed by:
Beth Spinelli
Project Officer, Drug Development Section
Office of Biodefense Research Affairs
E-mail: spinellb@niaid.nih.gov



Contact Info

Program Officers, their areas of responsibility, and contact information may be found at the DMID Staff Lists.

Overall coordination of the program is managed by:
Beth Spinelli
Project Officer, Drug Development Section
Office of Biodefense Research Affairs
E-mail: spinellb@niaid.nih.gov